A search for mutations in the DIA1 gene in case of hereditary methemoglobinemia type I in the Yakut population

Genetika

Volumn 39, Issue 6, 2003, Pages 858-862

  Nazarenko, L P ^a   Sazhenova, E A ^a   Nazarenko, S A ^a   Banschikova, E S ^b  

^a RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

^b National Center for Medicine   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B5 REDUCTASE;

ARTICLE; CONTROLLED STUDY; DIA1 GENE; EXON; GENE; GENE MUTATION; HEREDITARY METHEMOGLOBINEMIA; HUMAN; MISSENSE MUTATION; RACE DIFFERENCE; RUSSIAN FEDERATION;

EID: 33748686030     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Shirabe K., Yubisui T., Borgese N. et al. Enzymatic instability of NADH-cytochrom b5 reductase as a cause of hereditary methemoglobinaemia type I (red cell type) // J. Biol. Chem. 1992. V. 267. P. 20 416-20 421.
2. Katsube T., Sakamoto N., Kobayashi Y. et al. Exonic point mutations in NADH-cytochrom b5 reductase genes of homozygotes for hereditary methemoglobinaemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency // Am. J. Hum. Genet. 1991. V. 48. P. 799-808.
3. Jaffe E.R. Enzymopenic hereditary methemoglobinaemia: a clinical-biochemical classification // Blood Cells. 1986. V. 12. P. 81-90.
4. Tomatsu S., Kobayashi Y., Fukumaki Y. et al. The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene // Gene. 1989. V. 80. P. 353-361.
5. Hegesh E., Calmanovichi N., Avron M. New method for determining ferrihemoglobin reductase (NADH-methemoglobin reductase) in erythrocytes // J. Lab. Clin. Med. 1968. V. 72. P. 339.
6. Johns M.B., Paulus-Thomas J.E. Purification of human genomic DNA from whole blood sodium perchlorate in phase on phenol // Anal. Biochem. 1989. V. 180. P. 276-278.
7. Dekker J., Eppink M.H.M., van Zwieten R. et al. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b5 reductase gene leading to methemoglobinemia type I // Blood. 2001. V. 97. P. 1106-1114.
8. Wu Y., Huang C.H., Wan Y. et al. Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methemoglobinemia type I // Brit. J. Haematol. 1998. V. 102. P. 575-577.
9. Kugler W., Pekrun A., Laspe P. et al. Molecular basis of recessive congenital methemoglobinemia, types I and II: exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (Diaphorase I) gene // Hum. Mutat. 2001. V. 17. P. 348.
10. Wang Y., Wu Y.-S., Zheng P.-Z. et al. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia // Blood. 2000. V. 95. P. 3250-3255.
11. Jenkins J.M., Prchal J.T. A novel mutation found in the 3′ domain of NADH-cytochrom b5 reductase in an African-American family with type I congenital methemoglobinaemia // Am. Soc. Hematol. 1996. V. 87. P. 2993-2999.
12. Scott E.M. The relationship of diaphorase of human erythrocytes to inheritance of methemoglobinemia // J. Clin. Invest. 1960. V. 39. P. 1176-1179.
13. Scott E.M., Lewis M., Kaita H. et al. The absence of close linkage of methemoglobinemia and blood group loci // Am. J. Hum. Genet. 1963. V. 15. P. 493-494.
14. Balsamo P., Hardy W.R., Scott E.M. Hereditary methemoglobinemia due to diaphorase deficiency in Navajo Indians // J. Pediat. 1964. V. 65. P. 928-930.